Dexamethasone Sodium Phosphate + Neomycin SulphateThird Party Manufacturing in India

Dexamethasone Sodium Phosphate + Neomycin Sulphate works by cross-linking anti-inflammatory actions with broad bacterial protein synthesis inhibition. Dexamethasone acts on intracellular receptors to curb cellular exudate while neomycin targets the bacterial 30S ribosome to help the body minimize allergic or trauma-induced swelling while clearing bacterial pathogens. Unlike single anti-infective alternative classes, it ensures safety against concurrent secondary infections. It is highly effective and well-tolerated.

Therapeutic Uses

• Inflammatory Ocular Trauma: Reduces post-injury edema while protecting open tissues from bacteria.
• Allergic Otitis Externa: Controls severe itching and bacterial contamination in the ear canal.

Why Manufacturers Choose Dexamethasone Sodium Phosphate + Neomycin Sulphate

Establishing Dexamethasone Sodium Phosphate + Neomycin Sulphate third party manufacturing in India satisfies a major bulk procurement item for regional hospitals. Managed via primary molecule CAS number 2392-39-4, this combination is incredibly well established. Our partner facilities are WHO-GMP certified, running high-speed multi-dose liquid lines that maintain stability across varied storage conditions.